Human immunodeficiency virus type 1 Tat protein modulates cell cycle and apoptosis in Epstein–Barr virus-immortalized B cells
- 1 May 2004
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 295 (2) , 539-548
- https://doi.org/10.1016/j.yexcr.2004.01.018
Abstract
No abstract availableKeywords
Funding Information
- Fondazione Italiana per la Ricerca sul Cancro
- Istituto Superiore di Sanità
- Associazione Italiana per la Ricerca sul Cancro
This publication has 42 references indexed in Scilit:
- Epstein-Barr Virus-Induced Changes in B-Lymphocyte Gene ExpressionJournal of Virology, 2002
- The HIV-1 transactivator protein Tat is a potent inducer of the human DNA repair enzyme β-polymeraseAIDS, 2001
- Susceptibility of HIV-1-TAT transfected cells to undergo apoptosis. Biochemical mechanismsOncogene, 1999
- Interleukin-10 Gene Expression Induced by HIV-1 Tat and Rev in the Cells of HIV-1 Infected IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death.The Journal of Experimental Medicine, 1996
- The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.The Journal of Experimental Medicine, 1994
- Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell deathCell, 1991
- Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosisNature, 1991
- Establishment of an EBV‐positive lymphoblastoid cell line that grows as a lymphoma in nude mice and expresses membrane CD2 moleculesInternational Journal of Cancer, 1990
- Cellular uptake of the tat protein from human immunodeficiency virusCell, 1988